765948-78-5Relevant academic research and scientific papers
CARBAZOLE COMPOUNDS AND METHODS OF USING SAME
-
Paragraph 00121-00122; 00123, (2015/02/25)
The present invention provides carbazole compounds of the formula (I), which can be used for treating microbial, protozoan, viral infections and cancer. ?
FUSED INDOLE COMPOUNDS AND METHODS OF USING SAME
-
Paragraph 00119; 00120; 00121, (2015/04/22)
The invention relates to fused indole compounds of formula (I) that can be used for treating microbial infections, in particular, fungal infections, and selectively kill cancer cells.
CARBAZOLE COMPOUNDS AND METHODS OF USING SAME
-
Paragraph 00115; 00116; 00117, (2015/04/22)
The invention relates to carbazole compounds of formula (I) that can be used for treating microbial infections, in particular, fungal infections, and selectively kill cancer cells.
COMPOUNDS AND METHODS FOR TREATING CANCERS
-
Paragraph 0173; 0174, (2014/10/04)
Provided are carbazole and carbazole-like compounds (e.g., pyridoindole and pyrrolodipyridine compounds. The compounds can be used to selectively kill cancer cells.
IMIDAZOLE DERIVATIVE
-
Page/Page column 105, (2009/09/05)
A CB2 receptor modulator comprising an imidazole derivative represented by the general formula (I): [wherein, R1 represents optionally substituted lower alkyl or the like; R2 represents optionally substituted cycloalkyl or the like; R3 represents optionally substituted aryl or the like; and n represents an integer of 0 to 3] or a pharmaceutically acceptable salt thereof as an active ingredient, and the like are provided.
Isoindolinone kinase inhibitors
-
Page/Page column 16, (2010/02/10)
Compounds having the formula are useful for inhibiting protein tyrosine kinases. The present invention also discloses methods of making the compounds, compositions containing the compounds, and methods of treatment using the compounds.
Isoindolinone ureas: A novel class of KDR kinase inhibitors
Curtin, Michael L.,Frey, Robin R.,Heyman, H. Robin,Sarris, Kathy A.,Steinman, Douglas H.,Holmes, James H.,Bousquet, Peter F.,Cunha, George A.,Moskey, Maria D.,Ahmed, Asma A.,Pease, Lori J.,Glaser, Keith B.,Stewart, Kent D.,Davidsen, Steven K.,Michaelides, Michael R.
, p. 4505 - 4509 (2007/10/03)
A series of substituted isoindolinone ureas was prepared and evaluated for enzymatic and cellular inhibition of KDR kinase activity. Several of these analogs, such as 14c, are potent inhibitors of KDR both enzymatically (50nM) and cellularly (≤100nM). A 3D KDR/CDK2/MAP kinase overlay model with several structurally related tyrosine kinase inhibitors was used to predict the binding interactions of the isoindolinone ureas with the KDR active site.
ISOINDOLIN-1-ONE COMPOUNDS AS KINASE INHIBITORS
-
Page 34; 35, (2010/02/09)
Compounds having the formula, (I) are useful for inhibiting protein tyrosine kinases. The present invention also discloses methods of making the compounds and compositions containing the compounds.
